Aarti Pharmalabs Share Price

₹ 895.00

+₹22.30 (2.56%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: AARTIPHARM
|
Pharmaceuticals

Aarti Pharmalabs Share Price Today

As of 3 Nov 2026, Aarti Pharmalabs share price is ₹895.00. The stock opened at ₹873.20, compared to its previous close of ₹872.70. During today's trading session, Aarti Pharmalabs share price moved in the range of ₹870.05 to ₹898.55, with an average price of ₹884.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹585.00 and a high of ₹1,002.40. On the performance front, Aarti Pharmalabs share price has increased by 20.07% over the last six months and is up 4.33% on a year-on-year basis.

Share price over the last 1 day rose from 880.40 to 895.00, ranging between 873.90 and 897.10.
₹870.05
2.56% up today
₹898.55
1D LOW
1D HIGH

Aarti Pharmalabs Stock Insights

Latest Earning
Op Profit TrendDown by 6.01% QoQ
Latest Earning
Net Profit TrendDown by 6.13% QoQ
Latest Earning
Revenue TrendUp by 13.92% QoQ
Stock Performance
OutperformingBeat Nifty by 36.27 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 7.46%
Shareholding Pattern
DIIDII increased stake by 21.24%
Shareholding Pattern
FIIFII decreased stake by 0.25%
Aarti Pharmalabs stock performance
Open₹873.20
High₹898.55
Low₹870.05
Prev. close₹872.70
Aarti Pharmalabs trading activity
Volume4,64,241
Average traded price₹884.53
Last traded time03:29:55 02 Nov
Last traded quantity1
Circuit
L
H
₹698.20
₹1,047.20
52-week
L
H
₹585.00
₹1,002.40
Mkt Cap Cr
7,922.24
P/E
30.86
P/B
3.51
ROA
7.37%
ROE
8.22%
ROCE
9.59%
Quick Ratio
0.81
EV/EBITDA
17.06

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Aarti Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Aarti Pharma appears overvalued compared to its peers
Earnings: 2 out of 5, Poor
Earnings
Poor
Aarti Pharma earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Aarti Pharmalabs Company Background

ISIN
INE0LRU01027
Sector Market Cap
₹ 7,922.24 Cr

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.

Aarti Pharmalabs Financial Highlights

  • Revenue: Aarti Pharmalabs reported revenue of ₹1,829.19 crore in FY26 vs ₹2,125.19 crore in FY25. It showed a decrease of 13.93% on a yearly basis.
  • Operating Profit: Aarti Pharmalabs reported an operating profit of ₹232.92 crore in FY26 vs ₹360.69 crore in FY25. It showed a decrease of 35.42% on a year-on-year basis.
  • Net Profit: Aarti Pharmalabs reported a net profit of ₹174.71 crore in FY26 vs ₹272.40 crore in FY25. It showed a decrease of 35.86% on a yearly basis.

Aarti Pharmalabs Quarterly Result Highlights

  • Aarti Pharmalabs reported revenue of ₹610.92 crore in Sep 2026, compared with ₹536.25 crore in Jun 2026, representing an increase of 13.92% on a quarter-on-quarter (QoQ) basis.
  • Aarti Pharmalabs reported an operating profit of ₹94.99 crore in Sep 2026, compared with ₹101.06 crore in Jun 2026, representing a decrease of 6.01% on a quarter-on-quarter (QoQ) basis.
  • Aarti Pharmalabs reported a profit of ₹71.47 crore in Sep 2026, compared with ₹76.14 crore in Jun 2026, reflecting a decrease of 6.13% on a QoQ basis.
  • The earnings per share (EPS) of Aarti Pharmalabs stood at ₹19.27 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
39.66%
FII
8.15%
Other DII
7.80%
Retail and other
43.79%
Mutual funds
0.60%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20257.68%
Mar 20268.39%
Jun 20268.17%
Sep 20268.15%

Aarti Pharmalabs Investment Returns

1 day
+1.84%
1 week
+7.98%
1 month
-8.23%
1 year
+4.33%
3 years
+124.42%
5 years
+208.34%

Aarti Pharmalabs Share Price History

Aarti Pharmalabs share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹873.20 / ₹895.00
+2.56%
30 Oct 26
₹938.00 / ₹872.70
-5.92%
29 Oct 26
₹900.00 / ₹927.65
+5.18%
28 Oct 26
₹892.50 / ₹881.95
-0.45%
Show more

Aarti Pharmalabs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,819.44₹2,115.07₹1,852.61₹1,945.23
Other Income₹9.75₹10.12₹4.90₹2.32
Total Revenue₹1,829.19₹2,125.19₹1,857.50₹1,947.55
Total Expenses₹1,601.47₹1,764.50₹1,557.01₹1,686.78
Profit Before Tax₹232.92₹360.69₹300.49₹260.77
Tax₹58.21₹88.28₹83.59₹67.28
Profit After Tax₹174.71₹272.40₹216.90₹193.49
EPS - Basic₹19.27₹30.06₹23.93₹21.35
EPS - Diluted₹19.25₹30.04₹23.93₹21.35

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹227.72₹360.69₹300.49₹260.77
Income before WC changes₹415.82₹480.97₹395.14₹344.13
Change in Assets-₹177.20-₹29.39-₹165.20-₹161.83
Change in Liabilities₹70.25-₹56.91₹43.35₹130.20
Change in WC-₹106.96-₹86.31-₹121.85-₹31.63
Cash flow from Operations₹261.93₹330.14₹216.35₹250.12
Cash flow from Investing-₹430.72-₹412.48-₹214.56-₹157.80
Cash flow from Financing₹170.58₹65.43₹9.72-₹163.46
Total Cash Flow₹1.80-₹16.90₹11.51-₹71.15
Cash (Start of the year)₹6.73₹23.63₹12.12₹83.27
Cash (End of the year)₹8.53₹6.73₹23.63₹12.12

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,084.41₹1,584.24₹1,236.46₹1,081.02
Current Assets₹1,397.29₹1,322.17₹1,345.64₹1,163.01
Total Assets₹3,481.71₹2,906.41₹2,582.11₹2,244.02
Current Liabilities₹937.57₹657.05₹694.39₹600.62
Net Current Asset₹459.72₹665.12₹651.25₹562.38
Non-Current Liabilities₹419.53₹259.45₹130.68₹84.91
Equity Capital₹2,124.60₹1,989.91₹1,757.04₹1,558.49
Total Equity & Liabilities₹3,481.71₹2,906.41₹2,582.11₹2,244.02

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,797.55₹1,771.35₹1,502.13₹1,511.25
Other Income₹15.32₹12.80₹11.01₹1.28
Total Revenue₹1,812.87₹1,784.15₹1,513.14₹1,512.53
Total Expenses₹1,575.84₹1,447.81₹1,238.62₹1,279.17
Profit Before Tax₹234.24₹336.34₹274.52₹233.36
Tax₹58.04₹78.99₹73.87₹61.63
Profit After Tax₹176.20₹257.35₹200.65₹171.73
EPS - Basic₹19.44₹28.39₹22.14₹18.95
EPS - Diluted₹19.42₹28.38₹22.14₹18.95

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹234.24₹336.34₹274.52₹233.36
Income before WC changes₹417.66₹445.63₹355.23₹310.23
Change in Assets-₹194.50-₹87.56-₹168.87-₹129.45
Change in Liabilities₹80.84₹39.02₹44.32₹91.84
Change in WC-₹113.66-₹48.55-₹124.55-₹37.61
Cash flow from Operations₹257.26₹338.58₹183.69₹215.88
Cash flow from Investing-₹425.14-₹418.38-₹184.40-₹115.55
Cash flow from Financing₹170.58₹78.63₹4.40-₹156.53
Total Cash Flow₹2.70-₹1.16₹3.70-₹56.20
Cash (Start of the year)₹2.84₹4.00₹0.30₹56.50
Cash (End of the year)₹5.54₹2.84₹4.00₹0.30

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,934.33₹1,510.81₹1,162.85₹1,010.15
Current Assets₹1,393.43₹1,208.82₹1,134.06₹966.22
Total Assets₹3,327.76₹2,719.63₹2,296.91₹1,976.37
Current Liabilities₹925.88₹618.76₹555.58₹463.75
Net Current Asset₹467.55₹590.06₹578.48₹502.47
Non-Current Liabilities₹419.53₹257.00₹119.87₹74.04
Equity Capital₹1,982.35₹1,843.87₹1,621.46₹1,438.58
Total Equity & Liabilities₹3,327.76₹2,719.63₹2,296.91₹1,976.37
* All values are in INR Crore
Aarti Pharmalabs market depth
Bid quantityBid priceAsk priceAsk quantity
75888.800
0000
0000
0000
0000
Total bid quantity75
Total ask quantity0
Aarti Pharmalabs technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
49.91
Neutral
ATR (14)
44.71
Neutral
STOCH(9,6)
48.24
Neutral
STOCH RSI (14)
49.88
Neutral
ADX(9)
29.81
Bearish
UO(9)
54.34
Neutral
ROC(12)
-1.33
Bearish
WillR(14)
-51.76
Neutral
Period
Simple value
Exponential vaue
5D
878.26
879.75
10D
859.02
873.18
20D
883.13
874.6
50D
869.26
855.74
100D
788.52
813.55
Volume trend — traded volume by day
2 Nov4L
30 Oct6L
29 Oct34L
28 Oct4L
27 Oct5L
Average11L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Aarti Pharmalabs
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Aarti Pharmalabs

Fund name
AUM
Taurus Flexi Cap Fund
1.51%
UTI Healthcare Fund
0.84%
WhiteOak Capital Pharma and Healthcare Fund
0.61%

Aarti Pharmalabs Returns Calculator

Ex-date: 15 Sep 2026
Ex-date: 16 Feb 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Aarti Pharmalabs Share Price FAQs

Please be aware that Aarti Pharmalabs stock prices are subject to continuous fluctuations due to various factors.